Natasha M. Kafai - Concepedia

Author

Natasha M. Kafai

Washington University in St. Louis ORCID

Also Known As

Natasha Kafai, Natasha M Kafai, Natasha M. Kafai, Steinhardt, James J.

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

Washington University in St. Louis Howard Hughes Medical Institute University of Pittsburgh Vanderbilt University Medical Center Icahn School of Medicine at Mount Sinai

About

Natasha M. Kafai is an author at Washington University in St. Louis specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	3.2K
2	Immunology	11	11	3.2K
3	Engineering	1	1	43
4	Biomolecular Engineering	1	1	115
5	Microbiology	1	1	43

Natasha M. Kafai

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Potently neutralizing and protective human antibodies against SARS-CoV-2 Seth J. Zost, Pavlo Gilchuk, James Brett Case, Nature	2020	1.2K
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function Emma S. Winkler, Adam L. Bailey, Natasha M. Kafai, Nature Immunology Inflammatory Lung DiseaseLung InflammationSars-cov-2 InfectionViral PathogenesisImmunology	2020	979
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2 Ahmed O. Hassan, Natasha M. Kafai, Igor P. Dmitriev, Cell VaccinationVaccine SafetyVaccine DevelopmentLower Respiratory TractsImmunology	2020	614
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies Ahmed O. Hassan, James Brett Case, Emma S. Winkler, Cell VaccinationNeutralizing AntibodiesMedicineVaccine TargetHumoral Response	2020	561
The antigenic anatomy of SARS-CoV-2 receptor binding domain Wanwisa Dejnirattisai, Daming Zhou, Helen M. Ginn, Cell	2021	428
A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection Wafaa B. Alsoussi, Jackson S. Turner, James Brett Case, The Journal of Immunology VaccinationSars-cov-2 InfectionMedicineVaccine TargetMurine Model	2020	220
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice James Brett Case, Paul W. Rothlauf, Rita E. Chen, Cell Host & Microbe VaccinationSars-cov-2-mediated PathogenesisVaccine DevelopmentImmunologyViral Pathogenesis	2020	197
LDLRAD3 is a receptor for Venezuelan equine encephalitis virus Hongming Ma, Arthur S. Kim, Natasha M. Kafai, Nature Encephalitis VirusMolecular VirologyPathogenesisViral PathogenesisImmunology	2020	154
Rickettsia Sca4 Reduces Vinculin-Mediated Intercellular Tension to Promote Spread Rebecca L. Lamason, E Bastounis, Natasha M. Kafai, Cell MedicinePathogenesisImmunologyHelminth Infection	2016	137
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice Andrew C. Hunt, James Brett Case, Young‐Jun Park, Science Translational Medicine New VariantsViral DiagnosticsViral PathogenesisImmunologyMolecular Biology	2022	115

Page 1